Who reviews for predatory journals? A study on reviewer characteristics

Anna Severin(Swiss National Science Foundation), Tiago Barros(QB3), Michaela Strinzel(Swiss National Science Foundation), Matthias Egger(University of Zurich), Marc Domingo

bioRxiv (Cold Spring Harbor Laboratory)

March 11, 2020

10.1101/2020.03.09.983155

Cited by 11

Related Papers

Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis

|The Lancet|2018|3.5k

CINeMA: An approach for assessing confidence in the results of a network meta-analysis

|PLoS Medicine|2020|1.7k

Language bias in randomised controlled trials published in English and German

|The Lancet|1997|1k

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

|The Lancet Oncology|2016|738

Predatory journals: no definition, no defence

|Nature|2019|723